Literature DB >> 18802169

From bench to bedside: a case of rapid reversal of bortezomib-induced neuropathic pain by the TRPM8 activator, menthol.

Leslie A Colvin, Peter R E Johnson, Rory Mitchell, Susan M Fleetwood-Walker, Marie Fallon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18802169     DOI： 10.1200/JCO.2008.18.5017

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  13 in total

Review 1.  Symptom management in the older adult: 2015 update.

Authors:  Thomas J Smith
Journal:  Clin Geriatr Med       Date:  2015-03-03       Impact factor: 3.076

2.  Sustained Morphine Administration Induces TRPM8-Dependent Cold Hyperalgesia.

Authors:  Kerui Gong; Luc Jasmin
Journal:  J Pain       Date:  2016-11-12       Impact factor: 5.820

Review 3.  Therapeutic strategies for cancer treatment related peripheral neuropathies.

Authors:  Deirdre R Pachman; James C Watson; Charles L Loprinzi
Journal:  Curr Treat Options Oncol       Date:  2014-12

Review 4.  Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations.

Authors:  Bilal Mohty; Jean El-Cheikh; Ibrahim Yakoub-Agha; Philippe Moreau; Jean-Luc Harousseau; Mohamad Mohty
Journal:  Haematologica       Date:  2010-02       Impact factor: 9.941

Review 5.  Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives.

Authors:  Ilaria Saltarella; Concetta Altamura; Aurelia Lamanuzzi; Benedetta Apollonio; Angelo Vacca; Maria Antonia Frassanito; Jean-François Desaphy
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

6.  Bortezomib in the management of multiple myeloma.

Authors:  Jacob P Laubach; Constantine S Mitsiades; Teru Hideshima; Robert Schlossman; Dharminder Chauhan; Nikhil Munshi; Irene Ghobrial; Nicole Carreau; Kenneth C Anderson; Paul G Richardson
Journal:  Cancer Manag Res       Date:  2009-09-08       Impact factor: 3.989

Review 7.  Management options for established chemotherapy-induced peripheral neuropathy.

Authors:  Deirdre R Pachman; James C Watson; Maryam B Lustberg; Nina D Wagner-Johnston; Alexandre Chan; Larry Broadfield; Yin Ting Cheung; Christopher Steer; Dawn J Storey; Kavita D Chandwani; Judith Paice; Pascal Jean-Pierre; Jeong Oh; Jayesh Kamath; Marie Fallon; Herwig Strik; Susanne Koeppen; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2014-05-31       Impact factor: 3.359

8.  Cancer treatment-related neuropathic pain: proof of concept study with menthol--a TRPM8 agonist.

Authors:  M T Fallon; D J Storey; A Krishan; C J Weir; R Mitchell; S M Fleetwood-Walker; A C Scott; L A Colvin
Journal:  Support Care Cancer       Date:  2015-02-15       Impact factor: 3.603

Review 9.  Chemotherapy induced peripheral neuropathic pain.

Authors:  Hue Jung Park
Journal:  Korean J Anesthesiol       Date:  2014-07-29

10.  Anti-hyperalgesic effects of a novel TRPM8 agonist in neuropathic rats: a comparison with topical menthol.

Authors:  Ryan Patel; Leonor Gonçalves; Mathew Leveridge; Stephen R Mack; Alan Hendrick; Nicola L Brice; Anthony H Dickenson
Journal:  Pain       Date:  2014-07-30       Impact factor: 6.961
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.